Saturday Jul 19
The Town Talk
Roach: Doctor needs to have test re-done
Dear Dr. Roach: Recently, during a doctor's visit, my doctor informed me that my triglycerides had increased from about 200 three months ago to 417.
Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1I in db/db Mice.
Peroxisome proliferator-activated receptor -I , a lipid-sensing transcriptional factor, serves an important role in lipotoxicity.
Dr Reddy's launches lipid controlling drug in USA market
The drug which is indicated to reduce cholesterol and triglycerides in the blood was approved by the United States Food & Drug Administration , DRL said in a statement.
The Motley Fool
More Trouble Looming for Amarin Corporation?
Almost immediately after inking a co-promotional deal for the company's lone commercial product, Vascepa, with Kowa Pharmaceuticals America, Teva Pharmaceuticals announced yesterday they are launching a generic version of Lovaza.
Acasti Pharma: An Undervalued Biotech With A Potential Best-In-Class Omega-3 Drug
Acasti Pharma Inc. is a biopharmaceutical company focused on developing and commercializing innovative pharmaceutical ingredients for applications in cardiometabolic disorders.